168 related articles for article (PubMed ID: 22406932)
1. Nanog and Oct4 overexpression increases motility and transmigration of melanoma cells.
Borrull A; Ghislin S; Deshayes F; Lauriol J; Alcaide-Loridan C; Middendorp S
J Cancer Res Clin Oncol; 2012 Jul; 138(7):1145-54. PubMed ID: 22406932
[TBL] [Abstract][Full Text] [Related]
2. PHF19 and Akt control the switch between proliferative and invasive states in melanoma.
Ghislin S; Deshayes F; Middendorp S; Boggetto N; Alcaide-Loridan C
Cell Cycle; 2012 Apr; 11(8):1634-45. PubMed ID: 22487681
[TBL] [Abstract][Full Text] [Related]
3. Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation.
Kumar SM; Liu S; Lu H; Zhang H; Zhang PJ; Gimotty PA; Guerra M; Guo W; Xu X
Oncogene; 2012 Nov; 31(47):4898-911. PubMed ID: 22286766
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis.
Lang KC; Lin IH; Teng HF; Huang YC; Li CL; Tang KT; Chen SL
Am J Physiol Cell Physiol; 2009 Jul; 297(1):C43-54. PubMed ID: 19403798
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Oct4 and Nanog expression inhibits the stemness of pancreatic cancer cells.
Lu Y; Zhu H; Shan H; Lu J; Chang X; Li X; Lu J; Fan X; Zhu S; Wang Y; Guo Q; Wang L; Huang Y; Zhu M; Wang Z
Cancer Lett; 2013 Oct; 340(1):113-23. PubMed ID: 23872274
[TBL] [Abstract][Full Text] [Related]
7. Autochthonous mouse melanoma and mammary tumors do not express the pluripotency genes Oct4 and Nanog.
Schreiber C; Kuch V; Umansky V; Sleeman JP
PLoS One; 2013; 8(2):e57465. PubMed ID: 23468991
[TBL] [Abstract][Full Text] [Related]
8. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
9. Dynamic epigenetic regulation of the Oct4 and Nanog regulatory regions during neural differentiation in rhesus nuclear transfer embryonic stem cells.
Wang K; Chen Y; Chang EA; Knott JG; Cibelli JB
Cloning Stem Cells; 2009 Dec; 11(4):483-96. PubMed ID: 20025521
[TBL] [Abstract][Full Text] [Related]
10. Nanog suppresses cell migration by downregulating thymosin β4 and Rnd3.
Zhou Y; Li S; Huang Q; Xie L; Zhu X
J Mol Cell Biol; 2013 Aug; 5(4):239-49. PubMed ID: 23329853
[TBL] [Abstract][Full Text] [Related]
11. Conserved long noncoding RNAs transcriptionally regulated by Oct4 and Nanog modulate pluripotency in mouse embryonic stem cells.
Sheik Mohamed J; Gaughwin PM; Lim B; Robson P; Lipovich L
RNA; 2010 Feb; 16(2):324-37. PubMed ID: 20026622
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
13. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function.
Ramgolam K; Lauriol J; Lalou C; Lauden L; Michel L; de la Grange P; Khatib AM; Aoudjit F; Charron D; Alcaide-Loridan C; Al-Daccak R
PLoS One; 2011 Apr; 6(4):e18784. PubMed ID: 21526207
[TBL] [Abstract][Full Text] [Related]
14. Co-localization of NANOG and OCT4 in human pre-implantation embryos and in human embryonic stem cells.
Hambiliki F; Ström S; Zhang P; Stavreus-Evers A
J Assist Reprod Genet; 2012 Oct; 29(10):1021-8. PubMed ID: 22743827
[TBL] [Abstract][Full Text] [Related]
15. Effects of ectopic Nanog and Oct4 overexpression on mesenchymal stem cells.
Liu TM; Wu YN; Guo XM; Hui JH; Lee EH; Lim B
Stem Cells Dev; 2009 Sep; 18(7):1013-22. PubMed ID: 19102659
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of Oct4 and Nanog enhances malignancy in lung adenocarcinoma by inducing cancer stem cell-like properties and epithelial-mesenchymal transdifferentiation.
Chiou SH; Wang ML; Chou YT; Chen CJ; Hong CF; Hsieh WJ; Chang HT; Chen YS; Lin TW; Hsu HS; Wu CW
Cancer Res; 2010 Dec; 70(24):10433-44. PubMed ID: 21159654
[TBL] [Abstract][Full Text] [Related]
17. Differentiation of mouse embryonic stem cells after RNA interference-mediated silencing of OCT4 and Nanog.
Hough SR; Clements I; Welch PJ; Wiederholt KA
Stem Cells; 2006 Jun; 24(6):1467-75. PubMed ID: 16456133
[TBL] [Abstract][Full Text] [Related]
18. Effect of ectopic high expression of transcription factor OCT4 on the "stemness" characteristics of human bone marrow-derived mesenchymal stromal cells.
Guo X; Tang Y; Zhang P; Li S; Chen Y; Qian B; Shen H; Zhao N
Stem Cell Res Ther; 2019 Jun; 10(1):160. PubMed ID: 31159871
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.
Guo Y; Liu S; Wang P; Zhao S; Wang F; Bing L; Zhang Y; Ling EA; Gao J; Hao A
Histopathology; 2011 Oct; 59(4):763-75. PubMed ID: 22014056
[TBL] [Abstract][Full Text] [Related]
20. Nocodazole treatment decreases expression of pluripotency markers Nanog and Oct4 in human embryonic stem cells.
Kallas A; Pook M; Maimets M; Zimmermann K; Maimets T
PLoS One; 2011 Apr; 6(4):e19114. PubMed ID: 21559451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
